Intermolecular (NASDAQ:IMI) Upgraded by Credit Suisse Group to “Neutral”

Intermolecular (NASDAQ:IMI) was upgraded by investment analysts at Credit Suisse Group to a “neutral” rating in a research report issued to clients and investors on Thursday, Stock Target Advisor reports.

Separately, ValuEngine raised shares of Intermolecular from a “hold” rating to a “buy” rating in a research note on Thursday, August 1st.

NASDAQ:IMI opened at $1.19 on Thursday. The company has a quick ratio of 4.74, a current ratio of 4.74 and a debt-to-equity ratio of 0.43. Intermolecular has a fifty-two week low of $0.88 and a fifty-two week high of $1.25. The firm’s fifty day simple moving average is $1.19 and its 200-day simple moving average is $1.17.

Intermolecular (NASDAQ:IMI) last posted its quarterly earnings results on Thursday, August 8th. The semiconductor company reported ($0.11) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.03) by ($0.08). Intermolecular had a negative return on equity of 33.13% and a negative net margin of 42.74%. The company had revenue of $4.62 million for the quarter.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Gabelli Funds LLC acquired a new stake in Intermolecular in the 2nd quarter valued at about $2,421,000. Renaissance Technologies LLC lifted its holdings in Intermolecular by 6.5% in the 2nd quarter. Renaissance Technologies LLC now owns 1,583,367 shares of the semiconductor company’s stock valued at $1,853,000 after purchasing an additional 96,689 shares in the last quarter. GABELLI & Co INVESTMENT ADVISERS INC. purchased a new position in Intermolecular in the 2nd quarter valued at about $1,656,000. Water Island Capital LLC purchased a new position in Intermolecular in the 2nd quarter valued at about $1,167,000. Finally, Vanguard Group Inc. lifted its holdings in Intermolecular by 145.0% in the 2nd quarter. Vanguard Group Inc. now owns 854,257 shares of the semiconductor company’s stock valued at $999,000 after purchasing an additional 505,600 shares in the last quarter. 61.05% of the stock is currently owned by hedge funds and other institutional investors.

Intermolecular Company Profile

Intermolecular, Inc engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods.

Read More: Can systematic risk be avoided?

Stock Target Advisor

Receive News & Ratings for Intermolecular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular and related companies with MarketBeat.com's FREE daily email newsletter.